Society Recommendations Included in NIH Biomedical Workforce and Diversity Plans On Thursday, December 6, the Advisory Committee to the Director (ACD) of the National Institutes of Health (NIH) presented implementation plans to address issues related to the biomedical workforce. The ACD established two separate working groups...
FDA Fast-tracks Approval of New Medullary Thyroid Cancer Treatment On November 29 the Food and Drug Administration (FDA) approved Cometriq (cabozantinib) to treat metastatic medullary thyroid cancer. Cometriq is a kinase inhibitor that blocks abnormal kinase proteins involved in the development and growth of medullary cancer cells...
